Novo Nordisk is firmly committed to improving access to health

Novo Nordisk works to improve access to health. To learn about our positions on various aspects of access to health please see our publication Access to Health: Our Approach. The publication was launched in September 2011 and is the result of continuing consultations with NGOs, governments, healthcare professionals, patient organisations and other stakeholders.

Our efforts to ensure access to health are focused on those areas where we can make a difference through our core business activities, skills and research. The publication below presents the challenges and barriers we face in improving access to diabetes care. It takes stock of what we have achieved and learned over the past 10 years and identifies new areas of development where we will strive to further improve access to health in the years to come.


Full version 

Read the executive summary


Copies of the publication can also be ordered by emailing 

For further information on Novo Nordisk’s on-going access to health programmes and initiatives please visit 



Charlotte Ersbøll
Corporate Vice President,
Corporate Stakeholder Engagement
+45 3079 6511